Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease c syndrome
Phenotype C0005586|bipolar disorder
Sentences 15
PubMedID- 25410158 The relationship between lifetime suicide attempts, serum lipid levels, and metabolic syndrome in patients with bipolar disorders.
PubMedID- 20305595 However, investigations on the prevalence of metabolic syndrome in patients with bipolar disorder are still surprisingly rare.
PubMedID- 23293896 Comparative study of prevalence of metabolic syndrome in bipolar disorder and schizophrenia from north india.
PubMedID- 25042952 Conclusions: findings of the present study suggest the presence of cardiovascular risk factors and higher rate of metabolic syndrome in patients with bipolar disorder.
PubMedID- 23228159 Background: previous studies revealed high prevalence of metabolic syndrome (mets) in patients with bipolar disorder and schizophrenia.
PubMedID- 20492838 Conclusions: the prevalence of metabolic syndrome in patients with bipolar disorder is higher than that commonly reported in the general population.
PubMedID- 25742722 Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disorder and non-psychiatric controls.
PubMedID- 22056292 Purpose: to study the prevalence of metabolic syndrome in patients with bipolar disorder.
PubMedID- 24502861 Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression.
PubMedID- 23162184 Metabolic syndrome in bipolar disorders.
PubMedID- 20541810 Results: the rate of metabolic syndrome in individuals with bipolar disorder is increased relative to the general population.
PubMedID- 24330321 Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population.
PubMedID- 20562761 C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia.
PubMedID- PMC2991943 Reported prevalence of metabolic syndrome (mets) in patients with bipolar disorder varies from 18% to 32% in the european union (eu) and 40% to 49% in the united states of america (usa).
PubMedID- 21541294 Although smaller in number, other studies have shown increased prevalence of metabolic syndrome among patients with bipolar disorder and schizoaffective disorder as well, with a prevalence of 30 to 70% for bipolar disorder [6], [31], [46], [47], [48] and 42.4% to 67% for schizoaffective disorder [30], [31].

Page: 1